1 completed, 1 recruiting, 1 suspended. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Suspended 1 |
| Phase 2 | 1 | Completed 1 |
Follow Time-driven dosing: new trials by email Literature Review of Time-driven dosing trials Research Report on Time-driven dosing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diurnal Strength Variation Time-driven dosing - Healthy Adult, Exercise | Not applicable | Suspended | Stanford University | 20 | 2026-08-01 | 2026-09-28 |
| Sulfamethoxazole Prophylaxis Duration After Renal Transplantation Time-driven dosing - Fever, Chest Tightness | Not applicable | Recruiting | Anhui Provincial Hospital | 450 | 2024-05-28 | 2025-12-16 |
| The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP) Daily dosing, Time-driven dosing, Event-driven dosing - HIV Infections | Phase 2 | Completed | HIV Prevention Trials Network | 622 | 2011-08-01 | 2025-03-27 |
Fever (1) · HIV Infections (1) · Motor Activity (1)
Anhui Provincial Hospital (1) · HIV Prevention Trials Network (1) · Stanford University (1)
United States (2) · China (1) · South Africa (1) · Thailand (1)
Frits van Griensven, PhD, MPH (1) · Robert M. Grant, MD, MPH (1)